Analysis of calcium binding and release by canine cardiac relaxing system (sarcoplasmic reticulum). The use of specific inhibitors to construct a two-component model for calcium binding and transport.
D000251:Adenosine Triphosphatases / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D001151:Arsenic / Q000494:pharmacology; D001386:Azides / Q000494:pharmacology; D001665:Binding Sites; D001693:Biological Transport, Active / Q000187:drug effects; D002118:Calcium / Q000378:metabolism*; D003201:Computers; D004285:Dogs; D004721:Endoplasmic Reticulum / Q000187:drug effects / Q000201:enzymology; D006321:Heart / Q000187:drug effects; D006863:Hydrogen-Ion Concentration; D008274:Magnesium / Q000008:administration & dosage / Q000494:pharmacology; D008956:Models, Chemical; D009206:Myocardium / Q000166:cytology / Q000201:enzymology / Q000378:metabolism*; D009711:Nucleotides / Q000494:pharmacology; D010070:Oxalates / Q000494:pharmacology; D011485:Protein Binding; D012519:Sarcoplasmic Reticulum / Q000378:metabolism*; D013223:Statistics as Topic
D001386:Azides; D009711:Nucleotides; D010070:Oxalates; D000255:Adenosine Triphosphate; D000251:Adenosine Triphosphatases; D008274:Magnesium; D001151:Arsenic; D002118:Calcium